These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 572054)

  • 1. Tonic immobility: effects of dopamine receptor blockade and stimulation.
    Wallnau LB; Carnrike CL; Dewey GI
    Pharmacol Biochem Behav; 1979 Feb; 10(2):177-81. PubMed ID: 572054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tonic immobility in domestic fowl: possible interaction of serotonergic and dopaminergic mechanisms.
    Wallnau LB; Bordash GD; Corso P
    Pharmacol Biochem Behav; 1981 Apr; 14(4):469-73. PubMed ID: 7195036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of quipazine, fenfluramine and apomorphine on the morphine potentiation of tonic immobility.
    Wallnau LB
    Pharmacol Biochem Behav; 1981 Dec; 15(6):895-901. PubMed ID: 7323114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tonic immobility in domestic fowl: anticataleptic effects of quipazine.
    Wallnau LB
    Pharmacol Biochem Behav; 1980 Mar; 12(3):347-52. PubMed ID: 7190287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of drugs acting on the central dopaminergic neurons.
    Georgiev V; Markovska V
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():335-6. PubMed ID: 575925
    [No Abstract]   [Full Text] [Related]  

  • 7. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior.
    Weiner WJ; Carvey PM; Nausieda PA; Klawans HL
    Neurology; 1979 Dec; 29(12):1622-5. PubMed ID: 41197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs.
    Koller WC
    Psychopharmacology (Berl); 1984; 84(1):98-100. PubMed ID: 6436898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine and haloperidol on "spontaneous" stereotyped licking behaviour in the Cebus monkey.
    Korsgaard S; Povlsen UJ; Randrup A
    Psychopharmacology (Berl); 1985; 85(2):240-3. PubMed ID: 3925490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of arachidonic acid on stereotyped behavior in the rabbit induced by a dopamine receptor agonist].
    Kurchikov AL; Podol'skiĭ IIa; Bobylev RV; Ivanov VP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(4):783-5. PubMed ID: 3931383
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.